Thrombin is an allosteric serine protease existing in two forms, slow and fast, targeted toward anticoagulant and procoagulant activities. The slow 3 fast transition is induced by Na , and Lys 224 , and by three highly conserved water molecules in the D-Phe-Pro-Arg chloromethylketone thrombin. The sequence in the Na ؉ binding loop is highly conserved in thrombin from 11 different species and is homologous to that found in other serine proteases involved in blood coagulation. Mutation of two Asp residues flanking Arg 221a (D221A/D222K) almost abolishes the allosteric properties of thrombin and shows that the Na ؉ binding loop is also involved in direct recognition of protein C and antithrombin.
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Thrombin is a serine protease playing a key role in hemostasis (1, 2) . The enzyme is allosteric and exists in two forms, slow and fast (3). The slow form plays an anticoagulant role because it activates protein C (PC) 1 more specifically, generating a potent inhibitor of blood coagulation; the fast form has a procoagulant role because it cleaves fibrinogen with higher specificity, promoting the formation of a blood clot (4). The slow 3 fast transition is triggered by the specific binding of a Na ϩ ion (3, 5) . Other monovalent cations are less effective and bind with much lower affinity. Under physiological conditions of Na ϩ concentration, pH, and temperature, the slow and fast forms are almost equally populated (3) and help maintain the balance between procoagulant and anticoagulant activities that is crucial for effective hemostasis. Furthermore, the slow 3 fast equilibrium in vivo is under conditions where allosteric regulation is most efficient and can be exploited in much needed therapeutic treatments of thrombotic and bleeding disorders (2, 6) . Specific monovalent cation effects in proteins appear to be widespread and have been documented for a long time (7, 8) . In the realm of blood coagulation, these effects were first reported for factor Xa (9) and then for thrombin (10) and activated PC (11) . Monovalent cations can act as allosteric effectors, influencing the overall structure of an enzyme, or as cofactors that interact directly with substrates. Detailed structural information on the molecular basis underlying these effects has recently emerged for enzymes with specific requirement for K ϩ (12) (13) (14) . In the case of Na ϩ specific effects, as seen for thrombin, identification of the bound Na ϩ ion in the crystal structure is complicated by the comparable electron density of a water molecule and this monovalent cation. For this reason, the exact position of the Na ϩ binding site of thrombin has remained elusive, notwithstanding a number of crystallographic structures of the enzyme complexed with various ligands and inhibitors that have been reported in the presence of NaCl (15) . Given the crucial physiological effect of Na ϩ on thrombin (4), identification of the Na ϩ binding site should reveal key aspects of structure-function relationships for this important enzyme.
MATERIALS AND METHODS
Crystals of thrombin inhibited at the active site with PPACK were grown from sodium phosphate and PEG 8000 in the presence of NaCl as described previously (16, 17) . The mother liquor solution containing PPACK-thrombin crystals was exchanged with K ϩ ion solution of identical composition replacing Na ϩ with K ϩ ions (0.1 M potassium phosphate buffer, pH 7.3, 32% PEG 8000, 0.187 M KCl), by adding a 2-l aliquot to a 10-l hanging drop and withdrawing 2 l from the other side of the drop. This was done four times over 2 days. To complete the Na ϩ -K ϩ exchange, the crystals were transferred directly into 1 ml of the potassium solution. The Na ϩ -Rb ϩ exchange was accomplished using a capillary soaking method (18) with the potassium phosphate solution containing RbCl instead of KCl. The crystal was placed in a capillary tube used to mount crystals for diffraction purposes. Then 20 l of the potassium phosphate solution was placed over the crystal, upon which was layered 20 l of a similar solution that contained 1.88 M RbCl, followed by another 20-l layer of the potassium phosphate solution. Diffusion was allowed to take place for 90 h before removing the solution and mounting the crystal in a usual manner. The final concentration of the Rb ϩ ion in the capillary is estimated to be 0.625 M. The x-ray diffraction pattern of the Na ϩ ion exchanged crystal was measured with an R-AXIS imaging plate detector and used to determine and refine the Rb ϩ ion PPACK-thrombin structure (R ϭ 0.19 without solvent structure).
The double mutation D221A/D222K was obtained by amplification of the BglII/EcoRI sequence of pNUT-hII (19) using appropriate primers for the polymerase chain reaction. The double mutant was expressed in baby hamster kidney cells (BHK21) as prethrombin-1 using the pNUT vector constructed with the bovine factor V signal peptide and a 12-amino acid HPC4 epitope (20) . The prethrombin-1 mutant preceded by a 12-amino acid HPC4 epitope was purified on an HPC4 Affi-Gel 10 column. The zymogen form was activated, and the thrombin form was purified and tested for activity as described (21) .
Human ␣-thrombin was purified and tested for activity as described (3, 21) . Recombinant desulfatohirudin variant 1 (Revasc™) was ob-tained from Ciba-Geigy Pharmaceuticals (Horsham, United Kingdom). The concentration of hirudin was determined by amino acid analysis. Human fibrinogen, PC, antithrombin (AT), and rabbit lung thrombomodulin (TM) were from Hematologic Technologies (Essex Junction, VT). Heparin was from Sigma. The release of fibrinopeptides A and B (FpA and FpB), binding of hirudin, and cleavage of PC by the slow and fast forms of wild-type thrombin and the ARK mutant were studied and analyzed as described (4, 5) . Inhibition of thrombin activity by AT was studied using the procedure of Olson (22) and was analyzed using KINSIM and FITSIM (23, 24) to obtain the apparent second-order rate constant for formation of the thrombin-antithrombin complex (k on in Table II , and three highly occupied water molecules (Fig. 1) . It is located more than 15 Å away from 
FIG. 2. MOLSCRIPT plot (27) of the B-chain of human ␣-throm-
bin, derived from the coordinates of the thrombin-hirudin complex (26), with the inhibitor removed. The residues of the catalytic triad are shown at the interface between the two six-stranded ␤-barrels. The N terminus of the chain is at the bottom, and the C terminus is at the end of the ␣-helix at the top. Important structural domains of the enzyme are noted as follows: 1, Na ϩ binding loop; 2, autolysis loop; 3, fibrinogen binding loop; 4, heparin binding site. The Na ϩ ion is shown as a red ball in the loop connecting the last two ␤-strands of the B-chain terminating into the heparin binding site. Binding of Na ϩ to this loop induces the slow 3 fast transition and controls allosterically both the activity (3) and specificity (4) of the enzyme. The highly conserved fragment Cys 220 -Gly 226 of this loop (see Table I ) is in yellow. (Fig. 2) . The cavity traverses through thrombin from the active site to the opposite surface with Asp 189 near its midpoint. Very significantly, the channel is filled with about 20 water molecules, most of which are conserved in different thrombin structures. Furthermore, they are linked among each other by a complicated hydrogen bonding network, which also links up to the peptide chain of the protein and appears to stabilize the cavity. A Na ϩ ion and a water molecule are practically equivalent in an electron density map. Examination of different crystal structures of thrombin reveals an octahedrally coordinated water molecule at the Na ϩ site in over 20 of them, most with exceptionally small contacts to the central water molecule (2.2-2.4 Å).
FIG. 3. Value of the specificity constant for the hydrolysis of S2238 (H-D-
The sequence Cys
220
-Gly 226 involving the Na ϩ binding loop and part of the last ␤-strand of the B-chain is highly conserved in thrombin from 11 different species (Table I) , thereby supporting the fundamental role of Na ϩ binding in thrombin function. While Asp 222 is the only variable residue, Arg 221a is replaced by a Lys in the hagfish (28) . Comparison with analogous sequences in other serine proteases (Table I) indicates a high degree of homology, especially with factors IX and X and to a lesser extent with plasmin, PC, and factor VII. Homology is weaker between thrombin and pancreatic serine proteases like trypsin, chymotrypsin, and elastase. Hence, the architecture of the Na ϩ binding site of thrombin and the allosteric regulation based on the slow 7 fast equilibrium may be paradigmatic of a molecular strategy shared by other members of the blood coagulation cascade, like factors VII, IX, X, and PC, but not by pancreatic serine proteases. Proteases active in the blood might have evolved to exploit Na ϩ -dependent allosteric transitions to accomplish their multifunctional roles, taking advantage of the availability of this monovalent cation in the extracellular environment.
The allosteric nature of thrombin makes it possible to control its function by interfering with Na ϩ binding. A mutation involving the two Asp residues flanking Arg 221a (Table I) (26) , and most likely fibrinogen (30) . This double mutant D221A/D222K (ARK) has lost the ability to bind Na ϩ selectively (Fig. 3) and cleaves a synthetic substrate with nearly the same specificity in the presence of Li ϩ , Na ϩ , K ϩ , or the bulky cation Ch ϩ . The ARK mutant interacts with fibrinogen and hirudin with increased specificity in the slow form and reduced specificity in the fast form (Table II) . The perturbed energetics originate from an indirect effect, because the mutation impairs Na ϩ binding and stabilizes a conformation that is functionally and structurally intermediate between the slow and fast forms of the wild type. Circular dichroic spectra (Fig. 4 ) support this conclusion. The spectra for the slow and fast forms are significantly different for the wild type, but not The Na ϩ Binding Site of Thrombin 22091
